Hexameric tetrahedral rna nanostructures
AssigneesThe United States of America, as represented by the Secretary, Department of Health and Human Services, The Regents of the University of California
InventorsBruce A. Shapiro, Paul J. Zakrevsky, Luc Jaeger
Life of this patent
Estimating the term…
Abstract
Disclosed are nanostructures comprising a ribonucleic acid (RNA) scaffold comprising a hexameric tetrahedral core. The tetrahedral core may comprise four hexameric RNA nanorings linked together. Related pharmaceutical compositions, methods of modulating the expression of a target gene in a mammal, methods of treating or preventing a disease in a mammal, and methods of producing a hexameric tetrahedral RNA nanostructure are also disclosed.
Claims31
A nanostructure comprising a ribonucleic acid (RNA) scaffold comprising a hexameric tetrahedral core,
- wherein the tetrahedral core comprises four hexameric RNA nanorings linked together.
A nanostructure comprising a ribonucleic acid (RNA) scaffold comprising a hexameric tetrahedral core, wherein the tetrahedral core comprises:
- first, second, third, fourth, fifth, and sixth cross-over monomers;
- first, second, third, fourth, fifth, sixth, seventh, eighth, ninth, tenth, eleventh, and twelfth dumbbell monomers;
- wherein the first, second, and third dumbbell monomers and the first, second, and sixth cross-over monomers together form a first hexameric nanoring;
- wherein the fourth, fifth, and sixth dumbbell monomers and the fourth, fifth, and sixth cross-over monomers together form a second hexameric nanoring;
- wherein the seventh, eighth, and ninth dumbbell monomers and the first, third, and fifth cross-over monomers together form a third hexameric nanoring;
- wherein the tenth, eleventh, and twelfth dumbbell monomers and the second, third, and fourth cross-over monomers together form a fourth hexameric nanoring;
- and
- wherein each cross-over monomer is shared by two of the hexameric rings to link the hexameric nanorings together to form the hexameric tetrahedral core.
(canceled)
26-30. (canceled)
A method of producing a hexameric tetrahedral RNA nanostructure comprising:
- (a) forming “H”-shaped cross-over monomers, wherein each “H”-shaped cross-over monomer comprises two UA-handle three-way junctions (3WJs) linked together by a 7 base pair bridge to form the “H”-shaped cross-over monomer;
- (b) forming hexameric RNA nanorings, wherein each hexameric RNA nanoring includes three of the “H”-shaped cross-over monomers;
- and
- assembling the hexameric tetrahedral RNA nanostructure, wherein the hexameric tetrahedral RNA nanostructure comprises four of the hexameric RNA nanorings linked together via the “H”-shaped cross-over monomers.
Dependencies are inferred from the claim text.